The guidance was developed with a multi-agency advisory group, chaired by Dr Sophie Hallett, Cardiff University, which considered this evidence.
Datblygwyd y canllawiau ar y cyd â grŵp cynghori amlasiantaethol, dan gadeiryddiaeth Dr Sophie Hallett o Brifysgol Caerdydd, a ystyriodd y dystiolaeth hon.